ABSTRACT:
The reason oral drug delivery is the most convenient method is that it offers the largest active surface area for drug absorption of all delivery systems. Oral dosage forms like tablets and capsules are attractive because they can address issues of toxicity and ineffectiveness that may occur with traditional methods of oral administration. Controlled release (CR) and sustained release (SR) drug delivery systems are important innovations in dealing with challenges such as targeted drug delivery and managing the release rate to particular organs or tissues. These systems improve the bio-pharmaceutic, pharmacokinetic, and pharmacodynamic characteristics of drugs, allowing for dosing frequency reductions to as little as once per day. This leads to therapeutic advantages, including the maintenance of consistent plasma drug concentrations, reduction of local and systemic side effects, and optimization of the drug’s effectiveness with the smallest effective dose. This guarantees that patients will adhere to treatment better. This article examines different formulation strategies for controlled release drug delivery systems. Such systems provide medication at a pre-established rate for a designated duration, ensuring continuous, predictable, and reproducible kinetics via the gastrointestinal tract (GIT). They use drug-encapsulating devices that deliver therapeutic agents at controlled rates over prolonged periods, spanning from days to months. These systems have several advantages over traditional methods, such as the ability to customize drug release, safeguard sensitive medications, and enhance patient comfort and adherance.
Cite this article:
Prachi Ganesh Chaudhari, Sunila A. Patil, S.P. Pawar. A Controlled Release Drug Delivery Systems. Asian Journal of Pharmacy and Technology. 2025; 15(2):197-4. doi: 10.52711/2231-5713.2025.00031
Cite(Electronic):
Prachi Ganesh Chaudhari, Sunila A. Patil, S.P. Pawar. A Controlled Release Drug Delivery Systems. Asian Journal of Pharmacy and Technology. 2025; 15(2):197-4. doi: 10.52711/2231-5713.2025.00031 Available on: https://ajptonline.com/AbstractView.aspx?PID=2025-15-2-15
REFERENCES:
1. John, C., and Morten, C. (2002). The Science of Dosage Form Design Aulton: Modified Release Peroral Dosage Forms. Churchill Livingstone.
2. Nalla C, Gopinath H, Debjit B, Williamkeri I and Reddy TA. Modified release dosage forms. J Chem Pharm Sci. 2013; 6(1): 13-21.
3. Vyas, S.P., and Khar, R.K. (2002). Controlled Drug delivery: Concepts and Advances. Concepts and Advances. Vallabh Prakashan.
4. Shargel, L., and Yu, A.B.C. (1999). Modified release drug products. In: Applied Biopharmaceutics and Pharmacokinetics. McGraw Hill.
5. Ummadi S, Shravani B, Rao NGR, Reddy MS and Nayak BS. Overview on controlled release dosageform. Int J Pharm Sci. 2013; 3(4): 258-269.
6. Patnaik AN, Nagarjuna T and Thulasiramaraju TV. Sustained release drug delivery system: a modern formulation approach. Int J Res Pharm Nano Sci. 2013; 2(5): 586- 601
7. George, M., Grass, I.V., and Robinson, J. Modern Pharmaceutics. Marcel Dekker.
8. Pundir S, Badola A and Sharma D. Sustained release matrix technology and recent advance in matrix drug delivery system: A review. Int J Drug Res Tech. 2013; 3(1): 12-20.
9. Crank, J. (1975). The Mathematics of Diffusion. New York: Oxford Press.
10. Leon, L., and Herbert, L.A. (2002). Pharmaceutical Dosage Forms. New York: Marcel Dekker.
11. Kar RK, Mohapatra S and Barik BB. Design and characterization of controlled release matrix tablets of Zidovudine. Asian J Pharm Cli Re. 2009; 2: 54.
12. Salsa T, Veiga F and Pina ME. Oral controlled release dosage form. I. Cellulose ether polymers in hydrophilic matrices. Drug Develop Ind Pharm. 1997; 23: 929-938.
13. Kumar S, Shashikant and Bharat P. Sustained release drug delivery system: a review. Int J Inst Pharm Life Sci. 2012; 2(3): 356-376.
14. Cristina M, Aranzaz;u Z and Jose ML. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Re. 2011; 154: 2-19.
15. Theeuwes, F. Elementary Osmotic Pump. J Pharm Sci. 1975; 64, 1987–1991.
16. Mamidala R, Ramana V, Lingam M, Gannu R and Rao MY. Review article factors influencing the design and performance of oral sustained/controlled release dosage form. Int J Pharm Sci Nanotechnology. 2009; 2: 583.
17. Chugh I, Seth N, Rana AC and Gupta S. Oral sustained release drug delivery system: an overview. Int Res J Pharm. 2012; 3(5): 57-62.
18. Bhargava A, Rathore RPS, Tanwar YS, Gupta S and Bhaduka G. Oral sustained release dosage form: an opportunity to prolong the release of drug. Int J Adv Res Pharm Bio Sci. 2013; 3(1): 7-14.
19. Thakor RS, Majmudar FD, Patel JK and Rajpit JC. Review: osmotic drug delivery systems current scenario. J Pharm Res. 2010; 3(4): 771- 775.
20. Parashar T, Soniya, Singh V, Singh G, Tyagi S, Patel C and Gupta A. Novel oral sustained release technology: a concise review. Int Res J Dev Pharm Life Sci. 2013; 2(2): 262-269.
21. Modi K, Modi M, Mishra D, Panchal M, Sorathiya U and Shelat P. Oral controlled release drug delivery system: an overview. Int Res J Pharm. 2013; 4(3): 70-76.
22. Ratnaparkhi MP and Gupta JP, Sustained release oral drug delivery system - an overview. Int J Pharm Res Rev. 2013; 2(3): 11-21.
23. Shah N, Patel N, Patel KR and Patel D. A review on osmotically controlled oral drug delivery systems. J Pharm Sci Bio Res. 2012; 2(5): 230-237.
24. Thombre NA, Aher AS, Wadkar AV and Kshirsagar SJ. A review on sustained release oral drug delivery system. Int J Pharm Res Sch. 2015; 4(2): 361-371.
25. Dusane AR, Gaikwad PD, Bankar VH and Pawar SP. A review on: sustained released technology. Int J Res Ayu Pharm. 2011; 2(6): 1701-1708.
26. Swabrick, J., and Boylan, J.C. (1996). Encyclopedia of pharmaceutical technology. Newyork: Marcel Dekker.
27. Patel PN, Patel MM, Rathod DM, Patel JN, Modasiya MMK. Sustain Release Drug Delivery: A Theoretical Prospective. J Pharm Res. 2012; (8): 4165-4168.
28. Shamma SP, Haranath C, Reddy CPS and Sowmya C. An overview on SR tablet and its technology. Int J Pharm Drug Ana. 2014; 2(9):740-747.
29. Chauhan MJ and Patel SA. A concise review on sustained drug delivery system and its opportunities. Am J Pharm Tech Res. 2012; 2(2): 227-238.
30. Allen, L.V., Popvich, G.N., and Ansel, H.C. (2004). Ansel’s Pharmaceutical dosage forms and drug delivery system.
31. Robinson, J.R., and Lee, V.H. (1987). Controlled drug delivery. Marcel Dekker.
32. Kube RS, Kadam VS, Shendarkar GR, Jadhav SB and Bharkad VB. Sustained release drug delivery system: review. Int J Res Pharm Biotech. 2015; 3(3) 246:-251.
33. Mali AD and Bathe AS. A review on sustained release drug delivery system. GCC J Sci Tech. 2015; 1(4): 107-123.
34. Lapidus H and Lordi NG. Studies on controlled release formulations. J Pharm Sci, 1968; 57: 1292.
35. Kamboj S and Gupta GD. Matrix Tablets: An important tool for oral controlled release dosage forms. Pharmainfonet. 2009; 7: 1-9.
36. Lachman, L.; Lieberman, H. A.; Kanig J.L. Eds.; Theory and Practice of Industrial Pharmacy. 3rd ed Philadelphia, 1991, p.346-373.